T
TubeFolio
Back to Dashboard

STILL EARLY! Top 4 Robotics Stocks that are Better Than Nvidia

Fin TekMay 19, 2026

Summary

Kuran identifies "physical AI," or robotics powered by real-time intelligence, as the next trillion-dollar market opportunity, following the initial wave of AI investments like Nvidia. He emphasizes focusing on a company's products in a rapidly growing market. The robotics market is projected to grow 2.5 times over the next five years, surpassing $110 billion annually by 2030, excluding self-driving cars. Kuran highlights four non-obvious areas that will benefit from this revolution:

**Arm Holdings (ARM)**: Kuran views Arm as a crucial chip company with significant growth potential, being only about 10% of the value of larger AI chip companies. Its strength lies in designing chips for both edge computing (on-device processing, vital for robots) and data centers (for advanced training), without directly competing with GPU leaders like Nvidia. Arm's new AGI CPU for AI data centers is designed to complement existing GPUs, finding success with major customers. While strategically strong, Arm's short-term financials are expensive, and its new CPU's impact on earnings isn't expected until March 2028. Kuran suggests buying now before this impact is visible, positioning it as a medium-term bet where future revenue from its design business is key to its success.
**Symbotic (SMBC)**: Kuran sees Symbotic as a pure robotics play focusing on highly profitable warehouse automation. The stock recently dropped 20% despite achieving its first profitable quarter, which Kuran views as a market disconnect and a buying opportunity. Symbotic has strong revenue growth, improved gross profit, and a substantial $22 billion in contracted backlog, including a major deal with Walmart. The valuation has become "fairly reasonable" after its recent drop. Risks include high customer concentration and the critical need for successful operational execution to deploy systems at scale.
**Teradyne (TER)**: This company is highlighted as an overlooked investment, providing critical infrastructure for the robotics build-out. Teradyne manufactures automated test equipment for chips, which is increasingly vital as AI hardware becomes more complex, and also produces automation equipment, including collaborative robots through Universal Robotics (UR). The automated test equipment market is a concentrated duopoly expected to double by 2032. Teradyne's robotics division revenue grew 32% year-over-year. The trend of manufacturing reshoring also boosts demand for automation. Although the stock is currently expensive, Kuran believes the market isn't fully valuing the long-term growth potential of its robotics division, making it a "5-plus year investment" despite the company's cautious outlook on robotics growth.
**BOTZ (ETF)**: For investors not wanting to commit to a single company, Kuran recommends a robotics ETF. He prefers BOTZ over ROBO due to its lower fees and diversified holdings across various parts of the robotics value chain, including medical robots and international companies.

Mentioned Stocks

ARM
Sentiment: BUYAction: RECOMMENDED

Reasoning: Kuran identifies Arm as a crucial chip company with significant growth headroom, being only about 10% of the value of larger AI chip companies. It's strategically strong due to its position in both edge computing (critical for real-time robotic processing) and data center chips (AGI CPU, which complements, rather than competes with, leading GPUs). The robotics market is projected to grow significantly, and Arm's low-power mobile chip architectures are ideal for edge devices. Kuran notes that while current financials are expensive and the new AGI CPU's impact isn't expected until March 2028, buying now is crucial "because by the time it shows up, it's probably too late to buy in." He views it as a medium-term bet, with the condition that revenue from its design business starts materializing by 2028, otherwise he would re-evaluate and potentially sell.

Loading chart...
SMBC
Sentiment: BUYAction: RECOMMENDED

Reasoning: Kuran states Symbotic "looks like a much better buy at its current price" due to a market disconnect where the stock dropped 20% after reporting its first profitable quarter. He sees this as "an opportunity to buy the stock at a discount." Symbotic is a pure robotics play in the high-growth warehouse automation sector, boasting strong revenue growth, improved gross profit, net profitability, and a substantial $22 billion in contracted backlog, including a major deal with Walmart. Its valuation has moved from "very expensive" to "fairly reasonable." Kuran acknowledges the stock has higher risk due to customer concentration and execution challenges but offers "highest short-term potential reward" and potential for "multi-bagger return" if it executes well.

Loading chart...
TER
Sentiment: BUYAction: RECOMMENDED

Reasoning: Kuran likes Teradyne for a "5-plus year investment," viewing it as an overlooked way to invest in robotics through its critical infrastructure role. Teradyne manufactures automated test equipment for complex AI chips and also sells automation equipment, including collaborative robots via Universal Robotics (UR), which saw 32% year-over-year revenue growth. He believes the market is not fully valuing the robotics part of their business. Although the stock is "pretty expensive by most valuation metrics" and sensitive to slowdowns in AI spending (it dropped 18% after growth projections slowed), Kuran argues that its investment "only works if there's another area of growth that the market isn't factoring into the current stock price," which he believes is its growing robotics division.

Loading chart...
BOTZ
Sentiment: BUYAction: RECOMMENDED

Reasoning: Kuran recommends BOTZ as his "overall pick" for investors who prefer not to bet heavily on any single company and instead want exposure to the broader robotics space. He specifically chooses BOTZ over other robotics ETFs like ROBO because BOTZ has "lower fees and its holdings are spread across multiple parts of the robotics value chain," including medical robots and international companies, providing more diversified exposure.

Loading chart...